Arcutis Biotherapeutics, Inc. (ARQT)
Arcutis Biotherapeutics Market Cap : 3.561B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.561B |
| November 12, 2026 | 3.469B |
| November 11, 2026 | 3.576B |
| November 10, 2026 | 3.451B |
| November 09, 2026 | 3.302B |
| November 06, 2026 | 3.220B |
| November 05, 2026 | 3.402B |
| November 04, 2026 | 4.291B |
| November 03, 2026 | 4.033B |
| November 02, 2026 | 3.939B |
| October 30, 2026 | 4.028B |
| October 29, 2026 | 4.015B |
| October 28, 2026 | 3.950B |
| October 27, 2026 | 3.979B |
| October 26, 2026 | 3.995B |
| October 23, 2026 | 3.918B |
| October 22, 2026 | 4.044B |
| October 21, 2026 | 4.003B |
| October 20, 2026 | 4.122B |
| October 19, 2026 | 4.005B |
| October 16, 2026 | 3.620B |
| October 15, 2026 | 3.655B |
| October 14, 2026 | 3.317B |
| October 13, 2026 | 3.277B |
| October 12, 2026 | 3.293B |
| Date | Value |
|---|---|
| October 09, 2026 | 3.338B |
| October 08, 2026 | 3.076B |
| October 07, 2026 | 3.036B |
| October 06, 2026 | 3.004B |
| October 05, 2026 | 3.159B |
| October 02, 2026 | 3.160B |
| October 01, 2026 | 3.176B |
| September 30, 2026 | 3.319B |
| September 29, 2026 | 3.360B |
| September 28, 2026 | 3.432B |
| September 25, 2026 | 3.381B |
| September 24, 2026 | 3.299B |
| September 23, 2026 | 3.313B |
| September 22, 2026 | 3.489B |
| September 21, 2026 | 3.260B |
| September 18, 2026 | 3.187B |
| September 17, 2026 | 3.323B |
| September 16, 2026 | 3.283B |
| September 15, 2026 | 2.953B |
| September 14, 2026 | 3.048B |
| September 11, 2026 | 3.000B |
| September 10, 2026 | 2.936B |
| September 09, 2026 | 2.994B |
| September 08, 2026 | 3.063B |
| September 04, 2026 | 3.002B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.240B |
| ADMA Biologics, Inc. | 3.048B |
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Anika Therapeutics, Inc. | 179.48M |
| Savara, Inc. | 953.69M |
Market Cap Related Metrics
| PE Ratio | 131.08 |
| PS Ratio | 7.468 |
| Price to Book Value | 14.60 |
| Price to Free Cash Flow | 63.63 |
| Price | 28.26 |
| Earnings Yield | 0.76% |
| Operating PE Ratio | 108.04 |
| Normalized PE Ratio | 130.77 |